Men's

Guidelines (12)

Men's in the News

News in brief - January 2015 (updated)

News in brief - January 2015 (updated)

Other new launches, licence changes and updates relevant...

Xtandi: oral anti-androgen for metastatic prostate cancer

Xtandi: oral anti-androgen for metastatic prostate cancer

Xtandi (enzalutamide) is an anti-androgen licensed...

Zytiga approved for use before chemotherapy

Zytiga approved for use before chemotherapy

The licence for Zytiga (abiraterone) has been extended...

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases